IL119710A - Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide - Google Patents

Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide

Info

Publication number
IL119710A
IL119710A IL11971096A IL11971096A IL119710A IL 119710 A IL119710 A IL 119710A IL 11971096 A IL11971096 A IL 11971096A IL 11971096 A IL11971096 A IL 11971096A IL 119710 A IL119710 A IL 119710A
Authority
IL
Israel
Prior art keywords
pyrazolo
pyrimidin
acetamide
cyano
phenyl
Prior art date
Application number
IL11971096A
Other languages
English (en)
Other versions
IL119710A0 (en
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of IL119710A0 publication Critical patent/IL119710A0/xx
Publication of IL119710A publication Critical patent/IL119710A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
IL11971096A 1995-12-01 1996-11-28 Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide IL119710A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US785995P 1995-12-01 1995-12-01

Publications (2)

Publication Number Publication Date
IL119710A0 IL119710A0 (en) 1997-02-18
IL119710A true IL119710A (en) 1999-11-30

Family

ID=21728482

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11971096A IL119710A (en) 1995-12-01 1996-11-28 Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide

Country Status (25)

Country Link
US (1) US5714607A (sk)
EP (1) EP0776898B1 (sk)
JP (1) JP4112032B2 (sk)
KR (1) KR100439282B1 (sk)
CN (1) CN1057525C (sk)
AR (1) AR004822A1 (sk)
AT (1) ATE227290T1 (sk)
AU (1) AU718310B2 (sk)
BR (1) BR9605760A (sk)
CA (1) CA2191647C (sk)
CY (1) CY2440B1 (sk)
CZ (1) CZ292253B6 (sk)
DE (1) DE69624657T2 (sk)
DK (1) DK0776898T3 (sk)
ES (1) ES2184844T3 (sk)
HU (1) HU226398B1 (sk)
IL (1) IL119710A (sk)
MX (1) MX9605974A (sk)
NO (1) NO307181B1 (sk)
NZ (1) NZ299848A (sk)
PT (1) PT776898E (sk)
RU (1) RU2178415C2 (sk)
SK (1) SK281807B6 (sk)
TW (1) TW382629B (sk)
ZA (1) ZA9610008B (sk)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399621B1 (en) 1999-08-10 2002-06-04 American Cyanamid Company N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1, 5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
US20030091632A1 (en) * 1999-08-26 2003-05-15 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6485746B1 (en) 2000-08-25 2002-11-26 Neurocrine Biosciences, Inc. Controlled-release sedative-hypnotic compositions and methods related thereto
US6384221B1 (en) * 1999-09-02 2002-05-07 Neurocrine Biosciences, Inc. Polymorphs of N-methyl-N-(3-{3-[2-thienylcarbonyl]-pyrazol-[1,5-α]-pyrimidin-7-yl}phenyl)acetamide and compositions and methods related thereto
AU2001283119B2 (en) * 2000-08-03 2007-11-15 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
EP1526136A1 (en) * 2000-08-03 2005-04-27 Wyeth Polymorphs of zaleplon and methods for the preparation thereof
AR029780A1 (es) 2000-12-13 2003-07-16 Gador Sa Procedimiento mejorado para la obtencion de n-[3(3-ciano-pirazolo[1,5-a]pirimidin-7-il)fenil]-n-etil-acetamida
CA2450384A1 (en) * 2001-06-12 2002-12-19 Biogal Gyogyszergyar Rt. Process for the production of zaleplon
US20050032818A1 (en) * 2001-06-12 2005-02-10 Entire Interest N-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-5-yl)phenyl]-N-ethylacetamide and crystalline forms of zaleplon
CZ200471A3 (cs) * 2001-08-01 2004-11-10 Biogal Gyogyszergyar Rt Způsob purifikace N-[3-(3-kyanopyrazol[1,5-a]pyrimidin-7-yl)fenyl]-N-ethylacetamidu (zaleplon) a krystalické formy zaleplonu připravitelné tímto způsobem
US7034155B2 (en) 2002-02-14 2006-04-25 Cilag Ag Method for producing n-ethyl-n-[3-(3-cyanopyrazolo[1,5a]pyrimidine-7-yl)phenyl]acetamide
CN101426504A (zh) * 2002-02-15 2009-05-06 特瓦药厂私人有限公司 包含规定粒径分布的扎来普隆的粉末组合物和由其制得的药物制品
PL207322B1 (pl) * 2002-05-14 2010-11-30 Adamed Społka Z Ograniczoną Odpowiedzialnością Sposób wytwarzania zaleplonu
WO2005023813A1 (en) * 2003-09-04 2005-03-17 Cipla Limited Zaleplon synthesis
EP1691811B1 (en) 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
ES2338659T3 (es) * 2004-01-14 2010-05-11 Mallinckrodt, Inc. Metodo de dos fases para la sintesis de pirazolopirimidinas seleccionadas.
HUP0400325A3 (en) * 2004-02-02 2005-11-28 Richter Gedeon Vegyeszet Pure n-[3-(-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethyl-acetamide, process for its preparation and intermediates
DE602005018763D1 (de) 2004-02-18 2010-02-25 Sepracor Inc Dopamin-agonisten-kombinationstherapie mit sedativa zur verbesserung der schlafqualität
WO2006070244A2 (en) * 2004-11-22 2006-07-06 Bakulesh Mafatlal Khamar A process for the preparation of zaleplon
US7649007B2 (en) * 2006-08-15 2010-01-19 Wyeth Llc Oxazolidine derivatives as PR modulators
WO2008021337A1 (en) 2006-08-15 2008-02-21 Wyeth Oxazinan-2-one derivatives useful as pr modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
WO2008021309A1 (en) * 2006-08-15 2008-02-21 Wyeth Imidazolidin-2-one derivatives useful as pr modulators
WO2008068600A2 (en) * 2006-12-06 2008-06-12 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of zaleplo
CZ301145B6 (cs) 2008-07-31 2009-11-18 Farmak, A. S. Zpusob prípravy N-(1-benzo[b]thien-2-ylethyl)-N-hydroxymocoviny
CN102816163A (zh) * 2012-08-20 2012-12-12 四川禾邦阳光制药股份有限公司 扎来普隆的新晶型及制备方法
CN112694336B (zh) * 2020-12-29 2021-11-16 哈尔滨工业大学 一种高纯α相氮化硅纤维毡的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281000A (en) * 1979-07-09 1981-07-28 American Cyanamid Company Substituted pyrazolo (1,5-a)pyrimidines and their use as anxiolytic agents
US4626538A (en) * 1983-06-23 1986-12-02 American Cyanamid Company [7-(3-disubstituted amino)phenyl]pyrazolo[1,5-a]pyrimidines
NZ208554A (en) * 1983-06-23 1987-06-30 American Cyanamid Co (aryl and heteroaryl)-(7-(aryl and heteroaryl)-pyrazolo (1,5-a) pyrimidin-3-yl)-methanone derivatives and pharmaceutical compositions
US4521422A (en) * 1983-06-23 1985-06-04 American Cyanamid Company Aryl and heteroaryl[7-(aryl and heteroaryl)pyrazolo[1,5-a]pyrimidin-3-yl]methanones
JPS62270584A (ja) * 1986-04-28 1987-11-24 Yoshitomi Pharmaceut Ind Ltd ４，７−ジヒドロピラゾロ〔１，５−ａ〕ピリミジン誘導体
GB9321162D0 (en) * 1993-10-13 1993-12-01 Boots Co Plc Therapeutic agents

Also Published As

Publication number Publication date
DE69624657T2 (de) 2003-08-21
NZ299848A (en) 1998-09-24
HU9603275D0 (en) 1997-01-28
SK281807B6 (sk) 2001-08-06
ES2184844T3 (es) 2003-04-16
DK0776898T3 (da) 2003-02-24
CZ292253B6 (cs) 2003-08-13
RU2178415C2 (ru) 2002-01-20
CN1057525C (zh) 2000-10-18
CN1163893A (zh) 1997-11-05
CA2191647C (en) 2005-01-25
KR100439282B1 (ko) 2004-08-31
ATE227290T1 (de) 2002-11-15
HUP9603275A2 (en) 1997-08-28
AU718310B2 (en) 2000-04-13
HU226398B1 (en) 2008-11-28
CZ350596A3 (en) 1997-09-17
NO965084D0 (no) 1996-11-28
NO965084L (no) 1997-06-02
CA2191647A1 (en) 1997-06-02
EP0776898A1 (en) 1997-06-04
JPH09216885A (ja) 1997-08-19
US5714607A (en) 1998-02-03
DE69624657D1 (de) 2002-12-12
ZA9610008B (en) 1998-08-28
JP4112032B2 (ja) 2008-07-02
KR970042543A (ko) 1997-07-24
NO307181B1 (no) 2000-02-21
AU7409196A (en) 1997-06-05
CY2440B1 (en) 2004-11-12
HUP9603275A3 (en) 1997-10-28
PT776898E (pt) 2003-02-28
SK153696A3 (en) 1997-11-05
BR9605760A (pt) 1998-08-25
TW382629B (en) 2000-02-21
IL119710A0 (en) 1997-02-18
MX9605974A (es) 1998-04-30
AR004822A1 (es) 1999-03-10
EP0776898B1 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
IL119710A (en) Process for producing N-(3-(3-cyano- pyrazolo (1,5-a) pyrimidin-7- YL) phenyl)-N- ethyl-acetamide
GB2311522B (en) Process for producing perfluorocarbon
AU7495496A (en) Process for preparing 1,3-propanediol
NZ313165A (en) Process for producing n-substituted 3-hydroxypyrazoles
EP0857790A4 (en) METHOD FOR PRODUCING OPTICALLY ACTIVE AMINO COMPOUNDS
EP0765890A3 (en) Process for the preparation of a rubber composition
HUP9900377A3 (en) Novel process for preparing 2,3-dihydro-benzofuranol derivatives
EP0744395A4 (en) PROCESS FOR PRODUCING DIMETHYLAMINE
HUP9602960A2 (en) Process for producing alkylcarbazates
HUP9802054A3 (en) Process for producing 4,4,5,5,5-pentafluor-1-pentanol
HUP9802105A3 (en) Process for producing 2,3,4,5-tetrafluorbenzene derivatives
HUP9602988A3 (en) Process for producing 2-chloracrylnitril
EP0751111A3 (de) Verfahren zur Herstellung von 2,2-Dialkylaryliden-cycloalkanonen
HU9600316D0 (en) Process for producing n-(o-alkyl-phenyl)-imides
GR3030254T3 (en) Process for preparing substituted aminotriazolinones
AU5898696A (en) Process for producing aromatic nitriles
IL120556A0 (en) Process for the preparation of 3,3,5-trichloroglutarimide
HU9701476D0 (en) Process for producing dexfenfluramine hydrochloride
HUP9701064A2 (hu) Eljárás N-(2-karboxi-5-klór-fenil)-glicin előállítására
HUT76300A (en) Process for producing veratrumaldehyde
ZA96317B (en) Process for producing fishmeal
GB2302871B (en) Process for preparing 1,1-dioxo-cephem-4-ketones
HU9501132D0 (en) Process for producing of 6-methoxy-1-oxo-1,2,3,4-tetrahydronaphtalene
NZ272054A (en) Process for producing form 1 ranitidine hydrochloride
IL119112A0 (en) Process for the preparation of 4,6-dichloropyrimidines

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees